Information Library
Results for: Case Studies - Clinical and marketing materials
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Energizing Enrollment
October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
Advancing Vaccine Development in Australia and New Zealand
April 11, 2011
Quintiles rose to the challenge of a very aggressive vaccine recruitment timeline during the holiday period - and recruited 3,000+ subjects from 18-90 years of age within just 17 days - 25 days ahead of schedule. -
Superior Teamwork - Renal Transplants
February 2, 2011
901 patients were randomized according to the protocol timelines. The database lock was achieved 11 days before the original target date. -
Timely Results - Flu Vaccine
February 2, 2011
Streamlined processes for study startup, coupled with experience in vaccine trials and solid relationships with study sites and investigators, helped this Quintiles team meet the challenge of starting an influenza vaccine trial late in the influenza season. -
Bypassing Barriers - Refractory Partial Epilepsy
February 2, 2011
Despite a difficult and limited patient population, Quintiles randomized 388 patients (13 over target) 10 weeks ahead of schedule. -
Diabetes - Therapeutic Focus
February 1, 2011
A dose-ranging clinical study to evaluate the safety, efficacy and tolerability of five doses of Drug X compared with placebo in Type II diabetes patients with no prior exposure to anti-diabetic medication. -
Parkinson's Disease - Ambitious Recruitment
February 1, 2011
Quintiles provided project management, clinical monitoring, and more for a study of a drug for patients with early stage idiopathic Parkinson’s disease. -
Epilepsy - Refining Recruitment
February 1, 2011
Quintiles provided clinical monitoring and project management for a randomized, double-blind, parallel-group, placebo and comparator controlled multicenter study of Drug X in patients with epilepsy. -
Global Response HIV
February 1, 2011
Due to its global reach and extensive experience, Quintiles successfully managed 830 sites in 32 countries and recruited 14,521 patients. -
A Lock on Consistency
February 1, 2011
A double-blind, randomized, placebo-controlled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction.
